During the past decade, MetroHealth Cancer Care Center at MetroHealth Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 36 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MetroHealth Cancer Care Center at MetroHealth Medical Center" #1 sponsor was "Eastern Cooperative Oncology Group" with 27 trials, followed by "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "Gynecologic Oncology Group" with 11 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MetroHealth Cancer Care Center at MetroHealth Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 67 trials as a collaborator, "Eastern Cooperative Oncology Group" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "MetroHealth Cancer Care Center at MetroHealth Medical Center" are "Breast Cancer" (9 trials), "Lung Cancer" (8 trials), "Lymphoma" (6 trials), "Colorectal Cancer" (5 trials) and "Leukemia" (5 trials). Many other conditions were trialed in "MetroHealth Cancer Care Center at MetroHealth Medical Center" in a lesser frequency.

Most popular intervention types in "MetroHealth Cancer Care Center at MetroHealth Medical Center" are "Drug" (58 trials), "Biological" (24 trials), "Procedure" (15 trials), "Radiation" (15 trials) and "Other" (11 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (12 trials), "paclitaxel" (11 trials), "cisplatin" (10 trials), "carboplatin" (7 trials) and "cyclophosphamide" (6 trials). Other intervention names were less common.

The vast majority of trials in "MetroHealth Cancer Care Center at MetroHealth Medical Center" are 47 trials for "All" genders, 20 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "MetroHealth Cancer Care Center at MetroHealth Medical Center". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in MetroHealth Cancer Care Center at MetroHealth Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MetroHealth Cancer Care Center at MetroHealth Medical Center, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".